Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
17 Dec 2020	Submitted	Original manuscript
23 Dec 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
23 Dec 2020	Editorially accepted
11 Jan 2021	Article published	10.1186/s13063-020-04998-5

Back to article page